Skip to main content
Premium Trial:

Request an Annual Quote

NanoString, Leica Enter Comarketing Agreement

NEW YORK (GenomeWeb) – NanoString said today it has entered a comarketing agreement with Leica Biosystems.

Under the agreement, the companies will create a research workflow integrating NanoString's GeoMx Digital Spatial Profiling (DSP) instrument with Leica's Bond RX autostainer. Leica will be able to promote the GeoMx technology to its Bond RX customers, and NanoString will promote the Bond RX system to its GeoMX DSP customers.

According to NanoString, the integration will allow for more streamlined processing of tissue samples for applications like biomarker discovery.

Launched this week at the American Association for Cancer Research annual meeting, the GeoMx DSP platform allows for multiplexed spatial profiling of RNA and proteins.

"We have already used the Bond RX autostainer for many successful projects performed under our DSP Technology Access Program," Brad Grey, president and CEO of NanoString, said in a statement. "With the Bond RX and GeoMx DSP's compatible throughput, the two platforms together will provide an integrated and complete solution and should become a workhorse for any spatial profiling researcher."

Financial and other terms of the agreement were not disclosed.

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.